Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse

S. V. Szapiel, N. A. Elson, J. D. Fulmer, G. W. Hunninghake, Ronald Crystal

Research output: Contribution to journalArticle

292 Citations (Scopus)

Abstract

Evidence from divergent sources suggests that some forms of interstitial pulmonary disease are associated with abnormalities of the cellular immune system. To evaluate whether cellular immune processes are necessary determinants for the development of parenchymal alveolitis and fibrosis secondary to bleomycin, we examined the effect of bleomycin on the NIH, outbred white mouse as compared to the homozygous nude, athymic mouse on the NIH outbred background. The nude mouse has virtually no detectable cell-mediated immune function; we therefore hypothesized that if this component of the immune system were necessary for the development of bleomycin-induced interstitial disease, bleomycin would not induce the same pulmonary lesion in the nude mouse as in the white mouse. However, both white and nude mice developed alveolitis and fibrosis after intraperitoneal administration of bleomycin. Comparison of the frequency and severity of these lesions in the 2 groups revealed no significant differences. These findings suggest that the presence of an intact cell-mediated immune system is not an absolute requirement for the development of bleomycin-induced interstitial disease in the mouse. To the extent that this model is an appropriate approximation of human bleomycin-induced pulmonary disease, these results are consistent with the hypothesis that T-lymphocyte mediated processes are not primary determinants of this lesion.

Original languageEnglish
Pages (from-to)893-899
Number of pages7
JournalAmerican Review of Respiratory Disease
Volume120
Issue number4
Publication statusPublished - 1 Dec 1979
Externally publishedYes

Fingerprint

Interstitial Lung Diseases
Bleomycin
Nude Mice
Immune System
Fibrosis
Lung Diseases
T-Lymphocytes
Lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Szapiel, S. V., Elson, N. A., Fulmer, J. D., Hunninghake, G. W., & Crystal, R. (1979). Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. American Review of Respiratory Disease, 120(4), 893-899.

Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. / Szapiel, S. V.; Elson, N. A.; Fulmer, J. D.; Hunninghake, G. W.; Crystal, Ronald.

In: American Review of Respiratory Disease, Vol. 120, No. 4, 01.12.1979, p. 893-899.

Research output: Contribution to journalArticle

Szapiel, SV, Elson, NA, Fulmer, JD, Hunninghake, GW & Crystal, R 1979, 'Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse', American Review of Respiratory Disease, vol. 120, no. 4, pp. 893-899.
Szapiel, S. V. ; Elson, N. A. ; Fulmer, J. D. ; Hunninghake, G. W. ; Crystal, Ronald. / Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse. In: American Review of Respiratory Disease. 1979 ; Vol. 120, No. 4. pp. 893-899.
@article{01f4ccf9f5b54f83980ba7e939b8a05d,
title = "Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse",
abstract = "Evidence from divergent sources suggests that some forms of interstitial pulmonary disease are associated with abnormalities of the cellular immune system. To evaluate whether cellular immune processes are necessary determinants for the development of parenchymal alveolitis and fibrosis secondary to bleomycin, we examined the effect of bleomycin on the NIH, outbred white mouse as compared to the homozygous nude, athymic mouse on the NIH outbred background. The nude mouse has virtually no detectable cell-mediated immune function; we therefore hypothesized that if this component of the immune system were necessary for the development of bleomycin-induced interstitial disease, bleomycin would not induce the same pulmonary lesion in the nude mouse as in the white mouse. However, both white and nude mice developed alveolitis and fibrosis after intraperitoneal administration of bleomycin. Comparison of the frequency and severity of these lesions in the 2 groups revealed no significant differences. These findings suggest that the presence of an intact cell-mediated immune system is not an absolute requirement for the development of bleomycin-induced interstitial disease in the mouse. To the extent that this model is an appropriate approximation of human bleomycin-induced pulmonary disease, these results are consistent with the hypothesis that T-lymphocyte mediated processes are not primary determinants of this lesion.",
author = "Szapiel, {S. V.} and Elson, {N. A.} and Fulmer, {J. D.} and Hunninghake, {G. W.} and Ronald Crystal",
year = "1979",
month = "12",
day = "1",
language = "English",
volume = "120",
pages = "893--899",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "4",

}

TY - JOUR

T1 - Bleomycin-induced interstitial pulmonary disease in the nude, athymic mouse

AU - Szapiel, S. V.

AU - Elson, N. A.

AU - Fulmer, J. D.

AU - Hunninghake, G. W.

AU - Crystal, Ronald

PY - 1979/12/1

Y1 - 1979/12/1

N2 - Evidence from divergent sources suggests that some forms of interstitial pulmonary disease are associated with abnormalities of the cellular immune system. To evaluate whether cellular immune processes are necessary determinants for the development of parenchymal alveolitis and fibrosis secondary to bleomycin, we examined the effect of bleomycin on the NIH, outbred white mouse as compared to the homozygous nude, athymic mouse on the NIH outbred background. The nude mouse has virtually no detectable cell-mediated immune function; we therefore hypothesized that if this component of the immune system were necessary for the development of bleomycin-induced interstitial disease, bleomycin would not induce the same pulmonary lesion in the nude mouse as in the white mouse. However, both white and nude mice developed alveolitis and fibrosis after intraperitoneal administration of bleomycin. Comparison of the frequency and severity of these lesions in the 2 groups revealed no significant differences. These findings suggest that the presence of an intact cell-mediated immune system is not an absolute requirement for the development of bleomycin-induced interstitial disease in the mouse. To the extent that this model is an appropriate approximation of human bleomycin-induced pulmonary disease, these results are consistent with the hypothesis that T-lymphocyte mediated processes are not primary determinants of this lesion.

AB - Evidence from divergent sources suggests that some forms of interstitial pulmonary disease are associated with abnormalities of the cellular immune system. To evaluate whether cellular immune processes are necessary determinants for the development of parenchymal alveolitis and fibrosis secondary to bleomycin, we examined the effect of bleomycin on the NIH, outbred white mouse as compared to the homozygous nude, athymic mouse on the NIH outbred background. The nude mouse has virtually no detectable cell-mediated immune function; we therefore hypothesized that if this component of the immune system were necessary for the development of bleomycin-induced interstitial disease, bleomycin would not induce the same pulmonary lesion in the nude mouse as in the white mouse. However, both white and nude mice developed alveolitis and fibrosis after intraperitoneal administration of bleomycin. Comparison of the frequency and severity of these lesions in the 2 groups revealed no significant differences. These findings suggest that the presence of an intact cell-mediated immune system is not an absolute requirement for the development of bleomycin-induced interstitial disease in the mouse. To the extent that this model is an appropriate approximation of human bleomycin-induced pulmonary disease, these results are consistent with the hypothesis that T-lymphocyte mediated processes are not primary determinants of this lesion.

UR - http://www.scopus.com/inward/record.url?scp=0018629834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018629834&partnerID=8YFLogxK

M3 - Article

C2 - 92208

AN - SCOPUS:0018629834

VL - 120

SP - 893

EP - 899

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 4

ER -